Intoxication, Unintended Ingestion of Product
Conditions
Brief summary
This study aims to document the incidence and characteristics of spiking in the Ghent region, both anamnestically and by toxicological analysis. Spiking will be analyzed by immunoassay testing and high-resolution screening according to the protocol in the laboratory of UZ Gent;
Detailed description
This study aims at objectivating and characterizing the patients with alleged spiking in the city of Ghent. Every patient who presents at one of the four (out of four) emergency departments of Ghent, with a suspicion of spiking (drink/food/needle-spiking included), will be offered to take part of this study. The study entails a list of questions for the patient regarding demographics, recent own medication/drug/alcohol use and experienced symptoms; whilst the caregiver (doctor/nurse) completes a questionnaire regarding symptoms at time of presentation. For a presentation within 48h after event, both blood and urine samples are requested from the patient. When presenting between 48h and 96h after the event, only urine samples are requested. On this samples, IA and LC-GCMS according to the UNODOC standards (Guidelines for the Forensic analysis of drugs facilitating sexual assault and other criminal acts) to objectify exogenous products. On request of the patient, these results can be added to the medical file of the patient.
Interventions
DIAGNOSTIC_TESTserum and urine analysis
Spiking will be analyzed by immunoassay testing and high-resolution screening
Sponsors
University Hospital, Ghent
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* \>18 years * Patient self-reports suspicion of spiking OR there is a suspicion of spiking by physician, police, paramedics or patient's companions * willingness to provide urine and/or blood samples (depending on timing after event)
Exclusion criteria
* Reporting more than 5 days after spiking * Unable to reliably complete the questionnaire (can be after clinical observation/recovery). * Not declaring proficiency in the language in which informed consent is offered (Dutch/English). * Not agreeing to the informed consent. * Do not consent to blood and urine collection and/or analysis. * There is a suspicion of Drug Facilitated Sexual Assault (to be referred to Care Center Sexual Violence, ZSG, where parallel study is ongoing).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| What is the incidence of spiking in adult patients presenting to the emergency departments of the four Ghent hospitals with suspected spiking? | 19 months | Number of patients presenting to the ED with spiking |
| What is the type of product and mode of administration used in spiking | 19 months | Defining type of products and mode of administration |
| What are patient characteristics of patients with spiking | 19 months | Demographic features of the patients diagnosed with spiking |
| In what type of places does spiking occur in Ghent | 19 months | Location of spiking event |
Countries
Belgium
Outcome results
None listed